Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231

Anti-Cancer Drugs

Volumn 16, Issue 10, 2005, Pages 1083-1089

  Bigioni, Mario ^a   Benzo, Alfredina ^a   Irrissuto, Clelia ^a   Maggi, Carlo Alberto ^a   Goso, Cristina ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

Anti tumor effect; Breast cancer; Neuropeptides; Tachykinin receptor

Indexed keywords

DOXORUBICIN; ESTROGEN RECEPTOR; MEN 11467; NEPADUTANT; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; SUBSTANCE P; TACHYKININ RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; FEMALE; HOLLOW FIBER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOHEXYLAMINES; FEMALE; HUMANS; INDOLES; MICE; MICE, NUDE; MOLECULAR STRUCTURE; NEUROKININ A; PEPTIDES, CYCLIC; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RNA, MESSENGER; SUBSTANCE P; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 27644463170     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200511000-00007     Document Type: Article

References (18)

1. Rozengurt E. Neuropeptide as growth factors for normal and cancerous cells. Trends Endocrinol Metab 2002; 3:128-134.
2. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. The tachykinin peptide family. Pharmacol Rev 2002; 2:285-322.
3. Orosz A, Schrett J, Nagy J, Bartha L, Shon I, Nyeki O. New short-chain analogs of substance-P antagonist inhibit proliferation of human small cell lung-cancer cells in vitro and in vivo. Int J Cancer 1995; 60:82-87.
4. Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, et al. Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Invest 2003; 5:731-742.
5. Henning IM, Laissue JA, Horisberg U, Reubi J. Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 1995; 61:786-792.
6. Sharif M. Mitogenic signaling by substance P and bombesin-like neuropeptide receptors in astrocytic/glial brain tumor-derived cell lines. Int J Oncol 1998; 12:273-286.
7. Palma C, Bigioni M, Irrissuto C, Nardelli F, Maggi CA, Manzini S. Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft. Br J Cancer 2000; 2:480-487.
8. Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004; 64:2941-2955.
9. Singh D, Joshi DD, Hameed M, Qian J, Gascon P, Maloof PB, et al. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: Implication for bone marrow metastasis. Proc Natl Acad Sci USA 2000; 1:388-393.
10. Rao G, Patel PS, Idler SP, Maloof P, Gascon P, Potian JA, et al. Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Res 2004; 64:2874-2881.
11. 1 antagonist. Naum Schmied Arch Pharmacol 1998; 358:R324.
12. 2 receptor antagonist. Br J Pharmacol 1998; 123:81-91.
13. 2 receptor stably expressed in Chinese hamster ovary cells. Biochem Pharmacol 1999; 57:899-906.
14. UKCCCR. Guidelines for the Welfare of Animals in Experimental Neoplasia. Br J Cancer 1998; 1:1-10.
15. Geran RI, Greenberg NH, MacDonald MM, Schumacher AM, Abbott BJ. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 1972; 3:1-88.
16. Teicher Beverly A. Anticancer drug development guide. Totowa, New Jersey: Humana Press; 1997.
17. Hollingshead MG, Alley MC, Camalier RF, Abbott BJ, Mayo JG, Malspeis L, et al. In vivo cultivation of tumor cells in hollow fibers. Life Sci 1995; 2:131-141.
18. Arcamone F, Animati F, Berettoni M, Bigioni M, Capranico G, Casazza AM, et al. Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo. J Natl Cancer Inst 1997; 16:1217-1223.